About: Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 29 July 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2016 (ast) наукова стаття, опублікована в липні 2016 (uk) scientific article published on 29 July 2016 (en) مقالة علمية نشرت في 29 يوليو 2016 (ar)
publication date	wds:Q37139237-22543396-908C-4550-B776-60D05814C74D
publication date	2016-07-29 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37139237-95B847A6-CAE8-44C6-B0D5-7B44C479905E
language of work or name	English
exact match	wds:Q37139237-C5134E4C-AB4E-45B1-8E38-B5E7D7674E60
exact match	https://scigraph.springernature.com/pub.10.1186/s40064-016-2862-5
cites work	wds:Q37139237-025C6958-30C6-4810-BB82-87299C105399 wds:Q37139237-0D04BC4D-F292-4737-B195-9D7B86003F12 wds:Q37139237-19DC485F-A7C8-48BA-9132-4F19C908C637 wds:Q37139237-1C14B900-DE77-41CC-AD14-F22C337ED664 wds:Q37139237-20D664C1-1AC1-4251-99D9-0F7605D5BE1A wds:Q37139237-251F2FBE-EEF5-4E44-898B-FB7D362B2616 wds:Q37139237-2B9D3348-A42E-488E-8367-701E3B15888E wds:Q37139237-328CC6CA-4113-4E7B-9EBD-C79E34B46EF4 wds:Q37139237-343BC5DC-7FA5-4189-A97E-1BB6B9004F7F wds:Q37139237-3A7DF809-B53A-4833-AEAB-1B96200BEA20 wds:Q37139237-3ECCB103-19AF-4FC6-9572-DFD5D3330EEB wds:Q37139237-489B1636-2825-491A-A902-B5E3A89E9AE0 wds:Q37139237-4FCC9624-774D-4F83-A534-726CF4A96C8F wds:Q37139237-51DFE633-99B0-4816-A0FE-DF2FDA589E88 wds:Q37139237-571E2528-0AB8-4428-85FA-46CC31864518 wds:Q37139237-608E4EA4-8256-40C6-8F1B-D61573F6690F wds:Q37139237-695100E4-7165-467E-ADAD-DE1613CEBB0D wds:Q37139237-6A3AF777-8EE4-4317-8177-08C22E0BF0E9 wds:Q37139237-73397877-5E4C-45F3-AE86-F08A80762DF4 wds:Q37139237-740DB04D-96FB-4138-A1CB-2F95C91D42E7 wds:Q37139237-825D6017-BB54-4C8E-AFB7-8FA136BF8645 wds:Q37139237-83711DEF-D4EC-4103-977E-2DED7D37AF09 wds:Q37139237-84D1F222-2472-4A2D-B433-18B24C86E5DC wds:Q37139237-8FD98AE0-F65E-46AC-BE75-D9E0308BF6F0 wds:Q37139237-9539D544-B2C0-47CD-86D5-4D5192FECD36 wds:Q37139237-9FE64F10-49A6-4109-8F84-4CD25F7FB6BD wds:Q37139237-A8A95772-E2E1-4F0D-9409-23E4FB5FD510 wds:Q37139237-AC631102-7019-47EE-9119-C5FF6E6B1EE5 wds:Q37139237-B7EDF8F2-73FE-43D8-A0E5-6ABE297E16DE wds:Q37139237-C054F108-C30D-4D1D-8F69-35A70BA14F87 wds:Q37139237-C58856C1-D7F6-48D9-B054-4BAD1A1ADA3A wds:Q37139237-C655E1DB-EC19-47E0-8713-B5BF3633A7BA wds:Q37139237-CB6FAC39-5D05-4E0E-9B45-74CC744E70A4 wds:Q37139237-CC57557A-0796-4479-98BF-8313C8A3D05A wds:Q37139237-CE092237-CBA8-4A16-99DA-D588B296B6B2 wds:Q37139237-CFF05747-289A-40DE-96FB-E17D20B0F928 wds:Q37139237-D52F5743-831E-4EF1-97AC-C710D96BD694 wds:Q37139237-F618750D-C533-4670-8A73-9E671D1DD5D2 wds:Q37139237-F765E006-F94E-44C4-8A6F-CB1F8920BD26
cites work	Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry Psychological interventions for individuals with cystic fibrosis and their families Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries The Association Between Depression, Lung Function, and Health-Related Quality of Life Among Adults With Cystic Fibrosis "All at sea": the experience of living with cystic fibrosis. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents Spirometric reference values from a sample of the general U.S. population Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. A multi-method assessment of treatment adherence for children with cystic fibrosis Perceptions of barriers and facilitators: self-management decisions by older adolescents and adults with CF. Prevalence and impact of depression in cystic fibrosis Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care From Morisky to Hill-bone; self-reports scales for measuring adherence to medication Cystic fibrosis Predictive validity of a medication adherence measure in an outpatient setting Managed problem solving for antiretroviral therapy adherence: a randomized trial Quality of life in patients with Cystic Fibrosis: association with anxiety and depression International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety Pulmonary medication adherence and health-care use in cystic fibrosis. Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis Cystic fibrosis Tackling the increasing complexity of CF care A comparison of the Major Depression Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients. Employment in adults with cystic fibrosis Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample. Adherence of subjects with cystic fibrosis to their home program: a systematic review Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity Young people living with cystic fibrosis: an insight into their subjective experience Epidemiology of Cystic Fibrosis Screening for symptoms of depression and anxiety in adolescents and young adults with cystic fibrosis The 8-item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). Role of exercise and lung function in predicting work status in cystic fibrosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software